Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT
Key facts
- Who runs it
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 13 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional
- Treatments tested
- oXiris Hemofilter
- Record updated
- 8 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age 18 years or older
- Diagnosis of septic shock according to Sepsis-3 criteria: sepsis with persistent hypotension requiring vasopressors to maintain a mean arterial pressure of at least 65 mmHg and a blood lactate level greater than 2 mmol/L despite adequate fluid resuscitation
- Acute kidney injury classified as KDIGO stage 2 or 3
- A clinical decision by the treating team to initiate continuous renal replacement therapy (CRRT)
Who cannot take part
- Active major bleeding, a major bleeding event within the previous 48 hours, or severe uncorrected bleeding tendency
- Participation within the previous 6 months in another interventional study that may affect the outcomes of this study
- Confirmed or suspected heparin-induced thrombocytopenia, or a known severe allergy to heparin or the filter materials
- Severe irreversible end-stage organ failure with an expected survival of 48 hours or less
- The decision to initiate CRRT was made 24 hours or more before enrollment
- A documented decision to limit life-sustaining treatment or not to pursue invasive treatment
- Pregnancy or breastfeeding
- Written informed consent not obtained from the participant or legally authorized representative
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn whether continuous renal replacement therapy (CRRT) using the oXiris filter can lower the amount of endotoxin in the blood of adults with septic shock who need CRRT. Septic shock is a life-threatening condition caused by infection and severe organ dysfunction. CRRT is a form of continuous blood purification used to support the kidneys and manage fluid and waste products. The oXiris filter is designed to provide CRRT while also removing endotoxin and inflammatory substances from the blood.
Read full original descriptionShow less
The main questions this study aims to answer are:
Does 24 hours of CRRT with the oXiris filter lower blood endotoxin levels compared with levels before treatment? What changes occur in inflammation, organ function, and the need for medicines that raise blood pressure? What medical problems or treatment-related complications occur during the study?
This is a single-center study with no comparison group. About 13 participants will take part, and all participants will receive CRRT with the oXiris filter for a planned period of 24 hours. Other treatments for septic shock, including treatment for infection, fluids, medicines to support blood pressure, and other organ support, will be provided according to the hospital's usual care.
Researchers will:
Collect blood samples before and after the 24-hour oXiris treatment to measure endotoxin and markers of inflammation.
Record blood pressure, blood lactate, circulation, organ function, use of blood pressure medicines, and CRRT treatment information.
Continue selected blood tests and clinical assessments during the first 7 days Record any medical problems, including serious medical problems, during the study.
Check whether participants are alive at 28 days and 90 days after enrollment The study may help researchers better understand the biological effects and safety of the oXiris filter and provide information for larger future studies.
The group in the trial
- oXiris Hemofilter With CRRTTreatment being tested
Participants will receive CRRT using the oXiris hemofilter in continuous venovenous hemofiltration mode for a planned duration of 24 hours. CRRT settings, anticoagulation, fluid management, antimicrobial treatment, vasopressor support, and other organ support will follow standardized institutional protocols and clinical judgment. Blood samples and clinical assessments will be obtained before treatment and at the end of the 24-hour treatment period to evaluate changes in endotoxin levels, inflammatory markers, hemodynamics, organ function, and treatment-related safety events.
Treatment: oXiris Hemofilter
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of the oXiris Hemofilter on Early Endotoxin Burden in Patients With Septic Shock Requiring Continuous Renal Replacement Therapy: A Single-Center, Prospective, Single-Arm Clinical Trial
- Record updated
- 8 September 2026